Keyphrases
6-minute Walk Distance (6MWD)
10%
Abdominal Massage
7%
ACE Inhibitors
5%
Acidosis
7%
Adverse Events
16%
Allopurinol
7%
Angiotensin-converting Enzyme Inhibitor (ACEi)
13%
Antiviral Treatment
10%
Arterial Stiffness
5%
Arts Participation
5%
Asthma
7%
Atheroma Burden
6%
Atherosclerotic Burden
8%
Attention Deficit Hyperactivity Disorder
18%
Autoantibodies
10%
Between-group
9%
Between-group Difference
8%
Bicarbonate
10%
Blood Pressure
16%
Blood Test
5%
Body Mass Index
6%
Breast Cancer
9%
Breast Screening
7%
Cancer Awareness
7%
Cardiovascular Effects
5%
Care Pathway
7%
Chronic Effects
7%
Chronic Kidney Disease
9%
Chronic Obstructive Pulmonary Disease
5%
Clinical Efficacy
16%
Clinical Outcomes
11%
Clinical Trials
5%
Clinically Significant
8%
Cluster Randomized Trial
23%
Cognitive Behavioral Therapy
8%
Community Pharmacy
10%
Computed Tomography
7%
Confidence Interval
25%
Conventional Care
6%
Cost-effectiveness
17%
COVID-19
7%
Direct-acting Antivirals
5%
Drug Use
7%
Early Lung Cancer Diagnosis
10%
Effect Study
7%
Estimated Glomerular Filtration Rate
5%
Fall History
5%
Feasibility Randomised Controlled Trial
8%
Genotype
14%
HCV Treatment
5%
Hepatitis C
23%
Hepatitis C Treatment
10%
Hepatitis C Virus
26%
Hepatitis C Virus Infection
6%
Hepatitis C Virus RNA
5%
Image-guided Biopsy
7%
Intervention Group
23%
Invasive Breast Cancer
10%
Isolated Systolic Hypertension
7%
Kidney Disease Progression
8%
Left Ventricular Hypertrophy
8%
Left Ventricular Mass
5%
Leucine
16%
Lung
10%
Lung Cancer
17%
Lung Cancer Screening
12%
Meta-analysis
5%
Methylphenidate
27%
Methylphenidate Treatment
8%
Motivation
6%
Multiparametric MRI (mpMRI)
7%
Multiple Sclerosis
6%
Muscle Function
5%
Muscle Mass
16%
Muscle Strength
5%
Myotonic Dystrophy
14%
National Health Service
6%
Neurogenic Bowel
7%
Older Adults
5%
Older Patients
12%
Older People
35%
Opioid Agonist Treatment
5%
Opioid Substitution Treatment
12%
People Who Inject Drugs
19%
Perindopril
16%
Pharmacist-led
8%
Pharmacy
14%
Phosphocreatine Recovery
5%
Physical Function
16%
Physical Performance
22%
Pilot Randomized Controlled Trial
7%
Placebo
26%
Point-of-care
5%
Postural Sway
5%
Primary Care
9%
Prison
6%
Prostate Cancer
8%
Psychosocial Outcomes
6%
Quality of Life
18%
Quality-adjusted Life Years
7%
Randomized Controlled Trial
84%
Randomized Placebo-controlled Trial
10%
Randomized Trial
14%
Regress
5%
Sarcopenia
28%
School-based
7%
Scotland
33%
Scottish
11%
Shear Wave
7%
Short Message Service
7%
Short Physical Performance Battery
15%
Smoking Behavior
7%
Sodium Bicarbonate
7%
Sodium Bicarbonate Treatment
7%
Stiffness
7%
Stroke Rehabilitation
7%
Study within a Trial
6%
Sustained Virological Response
9%
SVR12
5%
Syrinx
5%
Tayside
16%
Text Messaging
8%
Treatment Effect
10%
Treatment Response
5%
Trial Registration
11%
Usual Care
15%
Variant Repeats
7%
Vascular Health
6%
Vitamin D
6%
Vitamin D Supplementation
8%
Vitamin K2
5%
Weight Loss
11%
Weight Management
5%
Whole-body
10%
Young Cancer Patients
5%
Medicine and Dentistry
25 Hydroxyvitamin D
6%
ACE Inhibitor
11%
Acidosis
7%
Adolescence
14%
Adverse Event
14%
Allopurinol
7%
Antiviral Therapy
5%
Apoplexy
5%
Arm
22%
Arterial Stiffness
7%
Attention Deficit Disorder
10%
Autoantibodies
11%
Biological Marker
7%
Biopsy Technique
6%
Blood Pressure
12%
Body Mass Index
8%
Breast Cancer
14%
Breast Screening
7%
Cancer Risk
5%
Cardiac Magnetic Resonance Imaging
7%
Cardiovascular Disease
9%
Care Pathway
5%
Chronic Kidney Disease
16%
Clinician
6%
Cognitive Behavioral Therapy
10%
Cohort Analysis
7%
Colecalciferol
5%
Colorectal Carcinoma
7%
Computer Assisted Tomography
6%
Cost-Effectiveness Analysis
10%
Cross Sectional Study
6%
Diagnosis
7%
Disease
7%
Drug Therapy
6%
Drug Use
7%
Glomerular Filtration Rate
5%
Health Care Cost
10%
Hepatitis C
17%
Hepatitis C Virus
16%
Image Guided Biopsy
7%
Incentive
7%
Infection
5%
Intention-to-Treat Analysis
6%
Left Ventricular Hypertrophy
8%
Leucine
15%
Lung
7%
Lung Cancer
18%
Lung Cancer Screening
7%
Lung Nodule
7%
Magnetic Resonance Imaging
12%
Meta-Analysis
6%
Methylphenidate
10%
Muscle Function
6%
Myotonic Dystrophy
10%
National Health Service
5%
Neoplasm
5%
Nicotine Withdrawal
5%
Perindopril
15%
Physical Activity
11%
Physical Performance
26%
Placebo
38%
Prevalence
5%
Primary Health Care
17%
Prostate Cancer
7%
Quality of Life
24%
Randomized Controlled Trial
100%
Sarcopenia
25%
Shear Wave Elastography
5%
Smoking
6%
Sodium Bicarbonate
11%
Supplementation
14%
Systematic Review
8%
Systolic Hypertension
7%
Treatment Effect
10%
Vitamin D
9%
Volunteer
7%
Weight Management
9%